Latest Conference Articles

Kenneth Gordon, MD, professor and chair of dermatology at the Medical College of Wisconsin, discusses new topical therapy treatment options for psoriasis and what he's looking forward to.

Melodie Young, MSN, A/GNP-C, nurse practitioner at Mindful Dermatology and a partner and sub-investigator with Modern Research Associates in Dallas, Texas, explains what NPs and PAs can bring to the dermatology space.

Meena Julapalli, MD, notes the sessions she is most looking forward to at the 2022 SPD 47th Annual Meeting in Indianapolis, Indiana.

Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the treatments for psoriatic arthritis, the comorbidities that have to be considered, and more.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, gives keys pearls on fillers and neuromodulators and what innovation is heading for the industry.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains what allied health care workers can learn from his presentation.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.

George Martin, MD and Ted Rosen, MD gave a 2-part comprehensive presentation on the changing landscape of cutaneous oncology at Maui Derm NP + PA Summer 2022.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, explores potential international technology that may transform the injectable space.

The top articles in recent literature offer a roadmap for new directions in dermatology practice.

Theodore Rosen, MD, presents the best therapies for central centrifugal cicatricial alopecia and fontal fibrosing alopecia.

Maui Derm NP+PA Summer 2022 Conference begins today in Colorado Springs, Colorado, offering a selection of in-person and virtual educational workshops and presentations.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, discusses what to expect from Maui Derm NP+PA Summer 2022 Conference.

Barbara McElroy, MSN, CRNI, VA-BC, shares her expert knowledge on placing IVs and treating patients to help health care workers optimize this procedure at the 2022 National Infusion Center Association Annual Conference.

Lindsey Savickas, RN, BSN, and COO at Infusion Associates, explains how infusion centers can support researchers in the dermatology space in discovering more effective treatments.

Barbara McElroy, MSN, CRNI, VA-BC, explains the responsibility a nurse has to their patient and how the Nurse Practicing Act needs to be more well-known.

Infusion centers are very much affected by legislative action on drugs. An expert offers insights into how best to navigate the situation.

Knowing advocacy types and how to get patients involved in advocating for themselves is a key topic in the medical world as drug access can become a confusing issue to tackle. A group of panelists at the 2022 NICA Annual Conference explained how clinicians can help their patients.

Robert Dracker, MD, MHA, MBA, CPI, medical director of Summerwood Pediatrics & Infusacare Medical Services, sits down to discuss why choosing an infusion center with pediatric experience will improve treatment outcomes.

Growth in new biologic treatments for widespread cutaneous disease along with innovation in medications for rare conditions such as generalized pustular psoriasis have moved infusion therapy from a nice-to-know to a need-to-know point on dermatologists’ continuing learning curve. The National Infusion Center Association provides answers to commonly asked questions about biologics in an informative presentation at the end of this article.

At the 2022 National Infusion Center Association Annual Conference, Kelly Gordon, PharmD, answered why diagnosing GPP is so difficult and what to look for to optimize patient care.

Robert Dracker, MD, MHA, MBA, CPI discussed considerations and developmentally appropriate interventions to promote high quality, patient-centered pediatric infusion care in a presentation at the 2022 National Infusion Center Association Annual Conference.

At the SDPA 2022 Annual Summer Dermatology Conference, a session on both common and rare dermatological disorders.

Lindsey Savickas, RN, BSN, and COO at Infusion Associates, explains how infusion centers and dermatologists are going to work together more as medications become more advanced.

Brian Nyquist, MPH, the CEO of the National Infusion Center Association (NICA), talks on the engaging sessions happening this weekend at the NICA conference and its growing importance to the dermatology community.

The 2022 National Infusion Center Association Conference will begin with several sessions focused on advocacy, clinical, management, and operations topics.